论文信息 - Phase I Trial of 131 I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients - 字舞流文

Phase I Trial of 131 I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients

A. Windhorst | N. Devoogdt | F. Duhoux | V. Caveliers | T. Lahoutte | M. Keyaerts | N. Hendrikse | H. Everaert | G. Raes | C. Fontaine | I. Vaneycken | Johannes Heemskerk | J. Eersels | F. Aa | M. Vanhoeij | D. Matthias | Huyvetter | Pieterjan Gykiere | J. Vos